tm logo
Live/Registered
REGISTERED

on 31 May 2022

Last Applicant/ Owned by

1-1, Marunouchi 1-chome, Chiyoda-ku

Tokyo

JP

100-8251

Serial Number

88880733 filed on 21st Apr 2020

Registration Number

6741952 registered on 31st May 2022

in the Principal Register

Correspondent Address

Danielle I. Mattessich

MERCHANT & GOULD P.C.

P.O. BOX 2910

MINNEAPOLIS, MN, 55402-0910

Filing Basis

1. intent to use

Disclaimer

NO DATA

Logo Mark Trademark Information

The mark consists of a hollow sphere design outlined by brush-strokes resembling blue, red, and white ribbons. The upper left part of the sphere has a blue stripe going to the bottom left, having a gleam and showing color gradation. The bottom part to the right side of sphere is outlined by a navy blue stripe. There is also a thin red stripe across the center of the sphere from the top to the bottRead More

Classification Information


Class [005]
Pharmaceutical Products


Cells for medical use; Stem cells for medical use; Pharmaceutical preparations containing cells for the treatment of hypoxic-ischemic encephalopathy, epidermolysis bullosa, cerebral infarction, stroke apoplexia cerebri, acute myocardial infarction, spinal cord injuries, amyotrophic lateral sclerosis (ALS), interstitial cystitis, acute respiratory distress syndrome (ARDS), peripheral arterial disease (PAD) and neonatal chronic lung disease (CLD); Pharmaceutical preparations containing stem cells for the treatment of hypoxic-ischemic encephalopathy, epidermolysis bullosa, cerebral infarction, stroke apoplexia cerebri, acute myocardial infarction, spinal cord injuries, amyotrophic lateral sclerosis (ALS), interstitial cystitis, acute respiratory distress syndrome (ARDS), peripheral arterial disease (PAD) and neonatal chronic lung disease (CLD); Pharmaceutical composition containing cells for the treatment of hypoxic-ischemic encephalopathy, epidermolysis bullosa, cerebral infarction, stroke apoplexia cerebri, acute myocardial infarction, spinal cord injuries, amyotrophic lateral sclerosis (ALS), interstitial cystitis, acute respiratory distress syndrome (ARDS), peripheral arterial disease (PAD) and neonatal chronic lung disease (CLD); Pharmaceutical composition containing stem cells for the treatment of hypoxic-ischemic encephalopathy, epidermolysis bullosa, cerebral infarction, stroke apoplexia cerebri, acute myocardial infarction,spinal cord injuries, amyotrophic lateral sclerosis (ALS), interstitial cystitis, acute respiratory distress syndrome (ARDS), peripheral arterial disease (PAD) and neonatal chronic lung disease (CLD)

Mark Details


Serial Number

No 88880733

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 594.807US01

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Design Code(s)

09.01.04 -

Ribbons, bows

26.01.21 -

Circles that are totally or partially shaded

26.17.09 -

Curved line(s), band(s) or bar(s)

26.19.01 -

Spheres

Description of Design Search

The mark consists of a hollow sphere design outlined by brush-strokes resembling blue, red, and white ribbons. The upper left part of the sphere has a blue stripe going to the bottom left, having a gleam and showing color gradation. The bottom part to the right side of sphere is outlined by a navy blue stripe. There is also a thin red stripe across the center of the sphere from the top to the bottom, and a white streak from the top right to the bottom left of the sphere. The light blue ribbon does not touch the dark blue ribbon. The background on which the design is placed and the center of the sphere represents transparent area.

Legal History


Show more

Status DateAction Taken
31st May 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
31st May 2022REGISTERED-PRINCIPAL REGISTER
26th Apr 20221(B) BASIS DELETED; PROCEED TO REGISTRATION
26th Apr 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
15th Mar 2022NOTICE OF ALLOWANCE CANCELLED
15th Mar 2022TEAS DELETE 1(B) BASIS RECEIVED
28th Dec 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
02th Nov 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02th Nov 2021PUBLISHED FOR OPPOSITION
13th Oct 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED